AIP
CSTL icon

Ameritas Investment Partners’s Castle Biosciences CSTL Stock Holding History

Ameritas Investment Partners’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.3K Hold
2,373
– – ﹤0.01% 2012
2025
Q4 		$92.3K Hold
2,373
– – ﹤0.01% 1758
2025
Q3 		$54K Sell
2,373
-527
-18% -$10.7K ﹤0.01% 2066
2025
Q2 		$59.2K Buy
2,900
+450
+18% +$8.33K ﹤0.01% 2078
2025
Q1 		$49K Hold
2,450
– – ﹤0.01% 2109
2024
Q4 		$65.3K Hold
2,450
– – ﹤0.01% 2026
2024
Q3 		$69.9K Hold
2,450
– – ﹤0.01% 1997
2024
Q2 		$53.3K Hold
2,450
– – ﹤0.01% 2110
2024
Q1 		$54.3K Hold
2,450
– – ﹤0.01% 2102
2023
Q4 		$52.9K Hold
2,450
– – ﹤0.01% 2138
2023
Q3 		$41.4K Buy
2,450
+779
+47% +$13.6K ﹤0.01% 2206
2023
Q2 		$22.9K Hold
1,671
– – ﹤0.01% 2496
2023
Q1 		$38K Hold
1,671
– – ﹤0.01% 2145
2022
Q4 		$45.1K Hold
1,671
– – ﹤0.01% 2130
2022
Q3 		$43K Hold
1,671
– – ﹤0.01% 2088
2022
Q2 		$36K Hold
1,671
– – ﹤0.01% 2202
2022
Q1 		$75K Hold
1,671
– – ﹤0.01% 1811
2021
Q4 		$72K Hold
1,671
– – ﹤0.01% 1893
2021
Q3 		$111K Hold
1,671
– – ﹤0.01% 1616
2021
Q2 		$123K Buy
1,671
+486
+41% +$32.1K ﹤0.01% 1594
2021
Q1 		$81K Buy
1,185
+186
+19% +$14K ﹤0.01% 1783
2020
Q4 		$67K Hold
999
– – ﹤0.01% 1805
2020
Q3 		$51K Buy
999
+175
+21% +$7.79K ﹤0.01% 1820
2020
Q2 		$31K Hold
824
– – ﹤0.01% 2105
2020
Q1 		$25K Buy
824
+514
+166% +$15.5K ﹤0.01% 2047
2019
Q4 		$11K Hold
310
– – ﹤0.01% 2686
2019
Q3 		$6K Buy
+310
New +$6.87K ﹤0.01% 2884

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's CSTL Position: Q1 2026 in Review

Ameritas Investment Partners held its Castle Biosciences (CSTL) position steady in Q1 2026 at 2,373 shares worth $58.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Ameritas Investment Partners first reported a position in CSTL in Q3 2019 and has held it in 27 quarters since. The position peaked at $123K in Q2 2021. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Ameritas Investment Partners held 2,373 shares of Castle Biosciences worth $58.3K as of Q1 2026.
  • Ameritas Investment Partners left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2012 holding.
  • Ameritas Investment Partners first reported a position in Castle Biosciences in Q3 2019 and has held it in 27 quarters since.
  • Ameritas Investment Partners's Castle Biosciences position peaked at $123K in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.